Intravenous Vitamin C and Cancer

For over half a century, high-dose intravenous vitamin C (IVC) has been explored as a promising adjunctive therapy in cancer care.   

In this webinar, Prof. Ian Brighthope will trace the scientific journey of vitamin C, from its historical use in scurvy prevention to its modern applications in cancer therapy, chemotherapy, radiotherapy, anaesthesia, and surgical recovery. Attendees will gain insights into the biochemical mechanisms of IVC including its ability to generate oxidative stress in tumour cells, modulate immune function, and enhance the efficacy of conventional treatments. 

Key topics include: 

• The history and evolving evidence for IVC in cancer management. 
• Mechanisms of action: oxidative stress, iron metabolism, epigenetic regulation, and immune enhancement. 
• Clinical applications: chemotherapy, radiotherapy, and peri-operative care. 
• Myths, controversies, and future directions for IVC in oncology.

Drawing on decades of clinical experience and research, Prof. Brighthope will present compelling evidence and real-world cases, while also addressing the limitations, safety concerns, and ongoing debates in the field. 

This webinar is designed for health practitioners seeking to expand their understanding of integrative oncology and the potential role of intravenous vitamin C as part of a holistic treatment approach.